跳至主要内容
临床试验/NL-OMON49218
NL-OMON49218招募中不适用

The Impact of Telemonitoring on correct drug Use, complications and quality of life among patients with Multiple Myeloma (MM);(ITUMM) - Telemonitoring among patients with multiple myeloma

Isala Klinieken0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, with informed consent, a
  • subject (patient) must meet all of the following criteria:
  • Patients meeting any of the following criteria may be included in the study:
  • Females and males >*18 years;
  • Diagnosis of multiple myeloma (NDMM patients);
  • Able to complete outcome measures;
  • Patients will be screened on minimal digital skills to check if they are able
  • to interact with an e-coach and whether they can read and understand the Dutch
  • language; estimated by the patient*s haematologist/oncologist
  • Patients have their own mobile (smart)phone, computer or tablet (20 iPads are
  • available for exceptions)
  • Every new diagnosed multiple myeloma patient qualifies for study
  • participation.

排除标准

  • potential subject who meets any of the following criteria will be excluded from
  • participation in this study:
  • Not prescribed oral medication for a MM treatment regime;
  • Psychiatric illness requiring secondary care intervention;
  • Too ill to engage with the intervention in the opinion of the clinical care

研究者

发起方
Isala Klinieken

相似试验

The Impact of Telemonitoring on correct drug Use,... | 临床试验